Targeting digoxin dosing to serum concentration: is the bullseye too small? - Wikidata - wikimedia - TriplyDB

Targeting digoxin dosing to serum concentration: is the bullseye too small?

Targeting digoxin dosing to serum concentration: is the bullseye too small?

http://www.wikidata.org/entity/Q54445922

about

Why is the use of digitalis withering? Another reason that we need medical heart failure specialists.

P2860

Q50100384-F2FEAF2B-6CA6-499A-897F-3DA329B5D044

P2860

Targeting digoxin dosing to serum concentration: is the bullseye too small?

http://www.wikidata.org/entity/Q54445922

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@en

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@nl

type

label

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@en

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@nl

prefLabel

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@en

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@nl

P1433

Q54445922-CAC10F5D-8529-4562-894C-552D76111DFB

P1476

Q54445922-767865A8-2F5F-46AA-839E-212D8CB79493

P2093

Q54445922-143C46DB-745C-4851-98D0-04EB8DDFDA39

P2860

Q54445922-0CED7A0D-32ED-44B3-9312-0401A6118E16

Q54445922-0D313B14-0EDB-43AE-AA56-6CA8F219FA4F

Q54445922-28E6BF4F-697C-47A8-8F8B-B7410ECF937F

Q54445922-37A970ED-B982-4ACF-9766-E8C364DD9CC4

Q54445922-4DB4A6CA-5D07-4C95-A310-EDF05FEE988E

Q54445922-6CD30DFE-7DDD-4856-93ED-1F20C938D948

Q54445922-82CF5D2F-46D3-422D-AB85-65D82E65FEEA

Q54445922-8383AC6D-AA35-42FF-9982-E98DB105D075

Q54445922-89D0C455-8D70-417B-90F1-E409044094C4

Q54445922-8CB75605-F7F8-463F-83DB-7821CD92DD1A

P304

Q54445922-EB8365E9-4A9B-4F7D-A1E9-E421BB25ACA9

P31

Q54445922-851a71a7-b30e-48b6-b536-b4c2d1a8d215

Q54445922-D458316F-7814-4F3B-BF89-3413736228A6

P356

Q54445922-D04276F9-3BC3-4307-80ED-0F57258415F0

P433

Q54445922-56464C9B-DE3A-4114-A378-F4E2C28124B7

P478

Q54445922-F7E0B755-C578-4EC0-82AE-C04E766DF0CC

P50

Q54445922-1467795C-32BF-41B2-8FAF-26AF35F545E5

P577

Q54445922-520401CE-EAE8-4F59-ADC6-8C56E0A0C5DE

P698

Q54445922-2FD3D148-2724-4B4D-A2D3-F02C7ECE36B3

P921

Q54445922-85800C90-7C52-4AEF-8E64-2F3E70A846D4

P356

P1433

European Journal of Heart Failure

P1476

Targeting digoxin dosing to serum concentration: is the bullseye too small?

@en

P2093

Andrew P Ambrosy

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT)

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

HFSA 2010 Comprehensive Heart Failure Practice Guideline.

The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions.

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure.

P304

1082-1084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJHF.589

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Mihai Gheorghiade

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27492642

http://www.w3.org/2001/XMLSchema#string

P921